Online Technical Meeting:
Challenges in the HPV Screening Landscape, Triage of Screening Positive Samples, and Screening in the Era of Vaccination
Online Meeting – August 2020
Meeting Objectives
- Landscape of HPV Screening
– Discuss barriers to adoption and implementation of HPV testing
– Review quality, validation and availability of HPV tests
– Provide country examples of successful implementation of HPV testing
– Discuss if we have enough options and supply needed for the global cervical cancer elimination
– Review HPV screening and treatment challenges in different regions
– Review challenges and opportunities to offer a complete system, from screening to treatment, in LMIC
– Discuss the existing networks that support the implementation of cervical cancer screening programs in LMICs.
- Triage: what are the best options.
– Review current available triage, treatment and management algorithms
– Discuss what are the best options for different situations
– Review challenges and future opportunities - Integration of Vaccination and Screening
– How to organize cervical cancer screening in the era of vaccination (Keynote Lecture) - Impact of COVID-19 on cervical cancer screening programs
Background Document (Pdf)
DAY 1 – Thursday, August 27th 2020
SESSION 1: OPENING AND OBJECTIVES
- Introduction & Welcome
Alex Vorsters
(Video)
SESSION 2: THE LANDSCAPE OF HPV SCREENING; WHERE DO WE STAND TODAY?
Chairs: Pierre Van Damme & Sharon Hanley
- Role of Screening in Cervical Cancer Elimination: What needs to be done at the level of vaccination, screening and treatment.
Nathalie Broutet
(Video)
- Quality Review, Validation and Availability of HPV tests– Quality Review, Validation and Availability of HPV tests: Commercially available HPV tests in 2020
Mario Poljak
(Video)– Validation of HPV tests usable for cervical cancer screening
Marc Arbyn
- WHO Prequalification of HPV diagnostic assays; pathway and recent developments
Anne – Laure Page
(Video)
- Experience from a prequalification reference lab: challenges and opportunities
Kate Cuschieri
(Video)
- Questions and Discussions
SESSION 3: HPV SCREENING AND TREATMENT; OPPORTUNITIES AND CHALLENGES IN DIFFERENT REGIONS.
Chairs: Murat Gultekin & Kate Cuschieri
- Cancer screening and early diagnosis in low- and middle-income countries: Current situation
Michael Chung
(Video)
- HPV screening and treatment challenges in Eastern and Central Europe: part of Europe with the highest burden of cervical cancer
Mario Poljak
(Video)
- Review of HPV/cervical cancer Screening and treatment challenges in Eastern Europe and Central Asia: Russia, Georgia, Belorussia, Ukraine, Moldova, Armenia, Azerbaijan, Uzbekistan, Kazakhstan, Kirgizstan.
Svetlana Rogovskaya & N.Chernova
- Implementation of organized HPV-based screening programs; Strategies, Challenges and Successes.
Sandra Van A. Dijk (Netherlands) (Video)
Murat Gültekin (Turkey) (Video)
- Implementation of regional HPV-based screening; Challenges and way forward to national implementation- Implementation of regional HPV-based screening; Challenges and way forward to national implementation. The Italian policy
Francesca Carozzi (Italy)
(Video)
- Road map to implementation of HPV-based screening; Halted implementation, Challenges and way forward.
Mark Van der Bulcke (Belgium)
(Video)
- Questions and Discussions
PANEL DISCUSSION – SHIFT FROM CYTOLOGY TO HPV TESTING; SOLUTIONS AND OPPORTUNITIES
Chairs: Eduardo Franco & Marc Arbyn
- Shift from Cytology to HPV Testing; Solutions and Opportunities
Panel Discussion
SESSION 2 CONTINUED: THE LANDSCAPE OF HPV SCREENING; WHERE DO WE STAND TODAY?
Chairs: Anna Giuliano & Susanne Krüger Kjaer
- Age at last screening and remaining lifetime risk of cervical cancer: a modelling study
Talia Malagon
(Video)
- Questions and Discussion
DISCUSSION SESSION
Chairs: Jesper Bonde & Alex Vorsters
The topics discussed were based on participants’ suggestions via poll
Elimination of HPV; does elimination targets lead to potential shortage of assays?/ Barriers and opportunities in Implementing cervical cancer screening and treatment
DAY 2 – Friday, August 28th 2020
SESSION 4: TRIAGE; CURRENTLY AVAILABLE OPTIONS, FUTURE OPPORTUNITIES AND CHALLENGES
Chairs: Suzanne Garland & Margaret Stanley
- What is needed for implementation of a complete system from screening to treatment in LMICs. Moving towards an organised cervical cancer screening, diagnosis and treatment in LMICs.
Silvia de Sanjose
(Video)
- Multicentric Study of Cervical Cancer Screening and Triage With Human Papillomavirus (HPV) Testing: The ESTAMPA Study
Maribel Almonte
(Video)
- HPV Screening, Triage and HIV infection.
Lynette Denny
(Video)
- Questions and Discussions
SESSION 5: EXISTING NETWORKS SUPPORTING IMPLEMENTATION OF CERVICAL CANCER PRECENTION AND CONTROL IN LOW RESOURCE SETTINGS.
Chairs: Silvia de Sanjose & Mira kojouharova
- Existing networks: Findings, Current Perspectives and Way forward
– Jhpiegos’ Programs, Perspectives and Priorities for Cervical Cancer and Prevention
Somesh Kumar – JHPIEGO
(Video)– The Scale-Up Project: Selected Results & Learnings from Adoption of HPV Testing for Cervical Cancer Screening in Central America
Kerry Thomson – PATH(Video)
- Questions and Discussions
SESSION 6: SCREENING IN THE ERA OF VACCINATION
Chairs: Francesca Carozzi & Nubia Muñoz
- Organizing cervical cancer screening in the era of vaccination (Keynote lecture)
Eduardo Franco
(Video)
- Questions and Discussions
SESSION 7: HPV PREVENTION AND CONTROL PROGRAMS IN PANDEMIC SITUATION
Chairs: Mario Poljak & Nathalie Broutet
SESSION 8: CONCLUSION
- Conclusion and concluding remarks
Marc Baay (Video) & Alex Vorsters